More About This Project — Bibliography

  1. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005; 293:2095-2101.
  2. Agency for HealthCare Research and Quality. An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer. Draft Evidence Report 2011.
  3. Anna Bill-Axelson, M.D., Ph.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Hans Garmo, Ph.D., Jennifer R. Stark, Sc.D., Christer Busch, M.D.,Ph.D., Stig Nordling, M.D., Ph.D., Michael Häggman, M.D., Ph.D., Swen-OlofAndersson, M.D., Ph.D., Stefan Bratell, M.D., Ph.D., Anders Spångberg, M.D.,Ph.D., Juni Palmgren, Ph.D., Gunnar Steineck, M.D., Ph.D., Hans-Olov Adami,M.D., Ph.D., and Jan-Erik Johansson, M.D., Ph.D., for the SPCG-4Investigators. Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer .N Engl J Med 2011;364:1708-17.
  4. Cheetham P, Truesdale M, Chaudhury S, Wenske S, Hruby GW, Katz A. Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate. J Endourol. 2010 Jul;24(7):1123-9. PubMed PMID:20575687.
  5. Crane, K. Surveillance May Be Suitable Treatment Option for Patients With Low-Risk Prostate Cancer. Press release JNCI July 2010.
  6. D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A, Kantoff P. 6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer a randomized controlled trial. JAMA. 2004; 292:821-827.
  7. Davis TC, Williams MV, Marin E, Parker RM, Glass J.
    Health literacy and cancer communication. CA Cancer J Clin. 2002;52:134-49.
  8. Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D et al.
    Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomized trial. Lancet. 1999;353:267-72.
  9. Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, Dahm P. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ. 2010 Sep 14;341:c4543. doi: 10.1136/bmj.c4543. Review. PubMed PMID: 20843937; PubMed Central PMCID:PMC2939952.
  10. Fagerlin A, Rovner D, Stableford S, Jentoft C, Wei JT, Holmes-Rovner M. Patient education materials about the treatment of early-stage prostate cancer: a critical review. Ann Intern Med. 2004;140:721-28.
  11. Feldman-Stewart D, Brundage MD, Hayter C, Groome P, Nickel JC, Downes H et al. What prostate cancer patients should know: variation in professionals' opinions. Radiother Oncol. 1998;49:111-23.
  12. Feldman-Stewart D, Brundage MD, Hayter C, Groome P, Nickel JC, Downes H et al. What questions do patients with curable prostate cancer want answered? Med Decis Making. 2000;20:7-19.
  13. Feldman-Stewart D, Brundage MD, Nickel JC, Mackillop WJ. The information required by patients with early-stage prostate cancer in choosing their treatment. BJU Int. 2001;87:218-23.
  14. Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Hoffman RM et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol. 2001;19:2517-26.
  15. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:917-29.
  16. Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Stewart ST, Bhatnagar V, Sweeney CJ, Stahl JE, McMahon PM. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010 Dec 1; 304(21):2373-80. Erratum in: JAMA. 2011 May 11;305(18):1862.
  17. PubMed PMID: 21119084; PubMed Central PMCID: PMC3055173.
  18. Health literacy rated low in one third of Medicare managed care enrollees. Am J Health Syst Pharm. 1999;56:709-10.
  19. Health literacy: report of the Council on Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. JAMA. 1999;552-57.
  20. Hegarty J, Beirne PV, Walsh E, Comber H, Fitzgerald T, Wallace Kazer M. Radical prostatectomy versus watchful waiting for prostate cancer. Cochrane Database Syst Rev. 2010 Nov 10;(11):CD006590. Review. PubMed PMID: 21069689.
  21. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002;347:781-89.
  22. Holmes-Rovner M, Stableford S, Fagerlin A, Wei JT, Dunn, RL, Ohene-Frempong J, Kelly-Blake K, Rovner, D. Evidence-based patient choice: a prostate cancer decision aid in plain language. 
    BMC Medical Informatics and Decision Making. 2005;5-16.
  23.  Hugosson J, Carlsson S, Aus G, et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. 2010:11:725-32.
  24. Incrocci L, Slob AK, Levendag PC. Sexual (dys)function after radiotherapy for prostate cancer: a review. Int J Radiat Oncol Biol Phys. 2002;52:681-93.
  25. Johansson J, Andren O, Andersson S, Dickman PW, Holmberg L, Magnuson A, Adami H. Natural history of early, localized prostate cancer. JAMA. 2004; 291:2713-719.
  26. Kalichman SC, Rompa D. Functional health literacy is associated with health status and health- related knowledge in people living with HIV-AIDS. J Acquir Immune Defic Syndr. 2000;25:337-44.
  27. Martin G. Sanda, M.D., Rodney L. Dunn, M.S., Jeff Michalski, M.D., Howard M. Sandler, M.D., Laurel Northouse, R.N., Ph.D., Larry Hembroff, Ph.D., Xihong Lin, Ph.D., Thomas K. Greenfield, Ph.D., Mark S. Litwin, M.D., M.P.H., Christopher S. Saigal, M.D., M.P.H., Arul Mahadevan, M.D., Eric Klein, M.D., Adam Kibel, M.D., Louis L. Pisters, M.D., Deborah Kuban, M.D., Irving Kaplan, M.D., David Wood, M.D., Jay Ciezki, M.D., Nikhil Shah, D.O., and John T. Wei, M.D. Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors. N Engl J Med 2008;358:1250-61.
  28. Matthew R. Cooperberg, Janet E. Cowan, Joan F. Hilton, Adam C. Reese, HarrasB. Zaid, Sima P. Porten, Katsuto Shinohara, Maxwell V. Meng, Kirsten L. Greene,and Peter R. Carroll. Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer J Clin Oncol 29:228-234.
  29. Mendenhall WM, Nichols RC, Henderson R, Mendenhall NP. Is radical prostatectomy the "gold standard" for localized prostate cancer? Am J Clin Oncol. 2010 Oct;33(5):511-5. Review. PubMed PMID: 20010078.
  30. Merriman B, Ades T, Seffrin JR. Health literacy in the information age: communicating cancer information to patients and families. CA Cancer J Clin. 2002;52:130-133.
  31. Miller DC, Hafez KS, Stewart A, Montie JE, and Wei JT. Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base. Cancer. 98(6):1169-78.
  32. Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin WP, and Wei JT. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. Journal of Clinical Oncology. 2005;23(12):2772-80.
  33. Mouraviev V, Johansen TE, Polascik TJ. Contemporary results of focal therapy for prostate cancer using cryoablation. J Endourol. 2010 May;24(5):827-34. Review. PubMed PMID: 20443724.
  34. Northouse LL, Mood DW, Montie JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, Sanda MG, and Kershaw T. Living with prostate cancer: patients' and spouses' psychosocial status and quality of life. J. Clin Oncol. 2007;25(27): 4171-177.
  35. Northouse LL, Mood DW, Schafenacker A, Montie JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, and Kershaw T. Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer. 2007;110(12):2809-18.
  36. Raveendhara R. Bannuru,Tomas Dvorak, Ndidiamaka Obadan, Winifred W. Yu, Kamal Patel, Mei Chung, and Stanley Ip.  Review Comparative Evaluation of Radiation Treatments for Clinically Localized Prostate Cancer: An Updated Systematic Review  Ann Intern Med June 6, 2011 E-347.
  37. Root J, Stableford S. Easy-to-read consumer communications: a missing link in Medicaid managed care. J Health Polit Policy Law. 1999;24:1-26.
  38. Sarma AV, Schottenfeld D. Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001. Semin Urol Oncol. 2002;20:3-9.
  39. Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA. 1999;281:1598-604.
  40. Siu-Long Yao, Grace L. Lu-Yao. Diagnosis of Localized, Screen-Detected, Prostate Cancer—Crisis or Opportunity? JNCI;102(13) July 7, 2010. Editorial.
  41. Smith MR. Effective treatment for early-stage prostate cancer--possible, necessary, or both? N Engl J Med. 2011 May 5;364(18):1770-2. PubMed PMID:21542749.
  42. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000;283:354-60.
  43. Stattin P, Holmberg E, Johansson JE, Holmberg L, Adolfsson J, Hugosson J; National Prostate Cancer Register (NPCR) of Sweden. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst. 2010 Jul 7;102(13):950-8. Epub 2010 Jun 18. PubMed PMID:20562373; PubMed Central PMCID: PMC2897875.
  44. Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlen BJ et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347:790-796.
  45. Taira AV, Merrick GS, Butler WM, Galbreath RW, Lief J, Adamovich E, Wallner KE. Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1336-42. Epub 2010 Jun 3. PubMed PMID: 20605342.
  46. Wei JT. To describe what men newly diagnosed with prostate cancer know or understand about prostate cancer, treatment options, side effects and quality of life. n/a. 1-41. 2002. Ann Arbor Michigan. Ref Type: Report.
  47. Wilt TJ, Brawer MK. The Prostate Cancer Intervention Versus Observation Trial (PIVOT).Oncology (Huntingt). 1997;11:1133-39.
  48. Wilt TJ, Roderick MacDonald, Indulis Rutks, Tatyana A. Shamliyan, Brent C. Taylor,and Robert L. Kane.Review Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer Ann Intern Med March 18, 2008 148:435-448.

Learn more about: :